Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2010
11/10/2010CN1845742B Method of stabilizing diarylvinylene compound
11/10/2010CN101880281A Thiophane nucleoside analogues and preparation method and application thereof
11/09/2010CA2479037C 2-amino-9[(2-hydroxymethyl)cyclopropylidenemethyl]purines as antiviral agents
11/04/2010WO2010126895A1 Inhibitors of pi3 kinase and / or mtor
11/04/2010WO2010126101A1 Purine derivative and antitumor agent using same
11/04/2010WO2010124648A1 Azaazulene compounds
11/04/2010WO2009152095A3 Nucleoside cyclicphosphates
11/04/2010US20100280040 Synthesis and pharmacokinetic activities of pulmodil and pulmodil-1, two chlorophenylpiperazine salt derivatives
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100279969 Azido purine nucleosides for treatment of viral infections
11/04/2010CA2760052A1 Communication means for communication with and remote activation of downhole tools and devices used in association with wells for production of hydrocarbons
11/04/2010CA2758986A1 Inhibitors of pi3 kinase and/or mtor
11/04/2010CA2747420A1 Azaazulene compounds
11/03/2010EP2246353A1 Method for producing adenine compound
11/03/2010EP2245031A2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
11/02/2010US7825126 (N)-methanocarba adenine nucleosides contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, cardiac arrhythmias and cardioprotection
11/02/2010US7825086 Acyclovir-peptide analogs
10/2010
10/28/2010US20100273802 New purine derivatives having, in particular, anti-proliferative properties, and their biological uses
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/27/2010EP2242758A1 Crystalline form of abacavir that is essentially free of solvent
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820815 Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines
10/21/2010WO2010120074A2 Method for preparing crystalline adefovir dipivoxil and adefovir dipivoxil butanolate used therein
10/21/2010US20100267953 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
10/21/2010US20100267941 Irna agents with biocleavable tethers
10/21/2010US20100267938 Use of antibody-surrogate antigen systems for detection of analytes
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/20/2010EP2240452A1 Certain chemical entities, compositions and methods
10/20/2010EP2240451A1 Certain chemical entities, compositions and methods
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010CN101863888A Medicaments with HM74a receptor activity
10/20/2010CN101863842A Entecavir midbodies and synthesis method
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/19/2010US7816398 Fatty alcohol drug conjugates
10/13/2010EP2238139A2 Method for preparing a marked purine derivative, said derivative and uses thereof
10/13/2010CN1946405B Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
10/13/2010CN101861318A Method of synthesis of morpholino oligomers
10/13/2010CN101861317A Antihistaminic and antiallergic agent and a method for the production thereof
10/13/2010CN101107249B Purine derivatives acting as a2a receptor agonists
10/13/2010CN101103030B Medicaments with HM74A receptor activity
10/07/2010WO2010114894A1 Substituted heterocyclic compounds
10/07/2010WO2010114494A1 8-substituted-2-morpholino purines for use as pi3k and/or mtor inhibitors in the treatment of proliferative disorders
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010114484A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256168 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256167 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010CA2757485A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
10/07/2010CA2756871A1 Substituted heterocyclic compounds
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101851240A Ganciclovir purification process
10/06/2010CN101851239A Ganciclovir recovery method
10/06/2010CN101851238A Substituted 8-heteroaryl xanthines
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807685 Therapeutic compounds
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111432A1 Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010WO2010110622A2 Novel crystal forms of adefovir dipivoxil and processes for preparing the same
09/30/2010WO2010110506A1 Dh-type crystalline form of adefovir dipivoxil, preparing method thereof, and pharmaceutical composition for antiviral agent comprising the same
09/30/2010WO2010108417A1 Method for preparing acyclovir 2/3 hydrate
09/30/2010WO2010085924A3 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
09/30/2010US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010US20100249154 Compositions useful for treating disorders related to trpa1
09/30/2010US20100249153 Substituted indolo-piperidine compounds
09/30/2010US20100249115 Substituted heterocyclic compounds
09/30/2010US20100249068 Substituted nucleoside and nucleotide analogs
09/30/2010US20100248272 Method for identifying Smk box riboswitch modulating compounds
09/30/2010CA2756347A1 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010CA2756067A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2231641A2 Quinoxaline and quinoline derivatives as kinase inhibitors
09/29/2010EP2231280A2 Organic compounds
09/29/2010CN1860364B Fluorescently tagged ligands
09/28/2010US7803974 reacting compound containing C Cl, C Br or C I bond (chlorobenzene, chlorofluorobenzene)with a hydrogenating agent ( H2) and a heterogeneous hydrogenation catalyst ( Pd/Al2O3) in the presence of an ionic liquid (cationic and anionic) for hydrodehalogenation
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2382631C Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
09/23/2010WO2010108051A2 Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof
09/23/2010WO2010106145A1 Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments
09/23/2010WO2010059401A3 Compounds that expand hematopoietic stem cells
09/23/2010US20100240681 Valomaciclovir polymorphs
09/23/2010US20100240680 Purine derivatives as a2a agonists
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240537 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives
09/22/2010EP2230239A1 A method for preparing 4-ý9-(6-aminopurine)¨-2-(s)-hydroxyl-butyric acid methyl ester
09/22/2010CN101210015B Method for preparing hepatitis B therapeutic medicament entecavir
09/21/2010US7799524 methods of transferring a label from novel substrates to O6-alkylguanine-DNA alkyltransferases (AGT) and O6-alkylguanine-DNA alkyltransferase fusion proteins, and to novel substrates suitable in such methods
09/21/2010CA2290614C Process for the preparation of polymers having nucleobases as side groups
09/16/2010WO2010103547A2 Substituted fused pyrimidine compounds
09/16/2010WO2010103473A1 Method of treatment of polycystic diseases and chronic lymphocytic leukemia
09/16/2010WO2010014921A3 A3 adenosine receptor antagonists and partial agonists
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 120